Castle Biosciences, Inc. (CSTL)
32.75
+0.35
(+1.08%)
USD |
NASDAQ |
Feb 06, 16:00
32.77
+0.02
(+0.06%)
After-Hours: 20:00
Castle Biosciences SG&A Expense (TTM) : 222.56M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| ANI Pharmaceuticals, Inc. | 304.67M |
| Delcath Systems, Inc. | 40.02M |
| CorMedix, Inc. | 75.56M |
| CytoSorbents Corp. | 38.05M |
| Odyssey Health, Inc. | 0.805M |